Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Hepatocellular × Sirolimus × 30 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms 3 Leukemia, Myeloid, Acute 3 Sarcoma 2 Rhabdomyosarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Myelodysplastic Syndromes 2 Lymphoma 2 Hematologic Neoplasms 2 Brain Neoplasms 2 Waldenstrom Macroglobulinemia 1 Skin Neoplasms 1 Sarcoma, Ewing 1 Rhabdomyosarcoma, Embryonal 1 Rhabdomyosarcoma, Alveolar 1 Rhabdoid Tumor 1 Pinealoma 1 PRETEXT I Hepatoblastoma 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasms, Germ Cell and Embryonal 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Multi-centric Castleman's Disease 1 Melanoma 1 Medulloblastoma 1 Macular dystrophy, corneal type 1 1 Lymphoproliferative Disorders 1 Lymphadenopathy 1

Interventions

Bevacizumab 13 atezolizumab 12 Specimen Handling 9 Nivolumab 8 durvalumab 6 pembrolizumab 4 X-Rays 4 Radiosurgery 4 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 lenvatinib 3 Sorafenib 3 Immunoglobulin G 3 E-7386 3 Cyclophosphamide 3 Blood Specimen Collection 3 sintilimab 2 regorafenib 2 cabozantinib 2 Disulfides 2 Biopsy 2 tremelimumab 1 tislelizumab 1 sofosbuvir-velpatasvir drug combination 1 sargramostim 1 sapanisertib 1 rocakinogene sifuplasmid 1 relatlimab 1 recombinant interferon alpha 2b-like protein 1 fludarabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡